GLAXOSMITHKLINE PLC
GSK
 Delayed - 07/27 11:38:11 am |
|
| 1399.2GBX | -0.04% |
Upcoming events on GLAXOSMITHKLINE PLC
| 07/28/21 | 07:00am | Interim 2021 Earnings Release |
| 07/28/21 | 09:00am | Interim 2021 Earnings Call |
| 10/27/21 | Q3 2021 Earnings Release |
| 02/09/22 | FY 2021 Earnings Release |
Past events on GLAXOSMITHKLINE PLC
| 06/29/21 | 02:00pm | Guggenheim Biopharma Strategy Series |
| 06/23/21 | 09:00am | Investor Meeting |
| 06/09/21 | European Hematology Association Congress - Abstract No EP1171 |
| 06/09/21 | European Hematology Association Congress - Abstract No EP1001 |
Upcoming sector events for GLAXOSMITHKLINE PLC
| 07/28/21 | 10:00am | PFIZER INC. : Interim 2021 Earnings Call |
| 07/28/21 | PFIZER INC. : Interim 2021 Earnings Release |
| 08/03/21 | 09:00am | ELI LILLY AND COMPANY : Interim 2021 Earnings Call |
| 08/03/21 | ELI LILLY AND COMPANY : Interim 2021 Earnings Release |
Past sector events for GLAXOSMITHKLINE PLC
| 07/22/21 | 08:30am | PFIZER INC. : Arvinas, Inc. and Pfizer Inc. ARV-471 Collaboration Agreement Call |
| 07/22/21 | 08:00am | ROCHE HOLDING AG : Interim 2021 Earnings Call |
| 07/22/21 | 01:00am | ROCHE HOLDING AG : Interim 2021 Earnings Release |
| 07/21/21 | 08:30am | JOHNSON & JOHNSON : Interim 2021 Earnings Call |
Annual results
| Fiscal Period : December | 2020 | 2021 | ||||||||||||
| Sales M GBP |
Released Forecast Spread | 34 099 34 076 0,07% | 33 019 | |||||||||||
| Operating income (EBITDA) M GBP |
Released Forecast Spread | 9 530 10 575 -9,9% | 9 419 | |||||||||||
| Operating profit (EBIT) M GBP |
Released Forecast Spread | 8 906 8 955 -0,55% | 8 056 | |||||||||||
| Pre-Tax Profit (EBT) M GBP |
Released Forecast Spread | 6 968 6 738 3,4% | 5 391 | |||||||||||
| Net income M GBP |
Released Forecast Spread | 5 749 4 894 17% | 3 385 | |||||||||||
| EPS GBP |
Released Forecast Spread | 1,14 0,97 18% | 0,69 | |||||||||||
| Announcement Date | 02/03/2021 | - | ||||||||||||
| ||||||||||||||
Previous year
Quarterly / Semiannualy publications
| Fiscal Period : December | 2021 Q1 | 2021 Q2 | ||||||||||||||||||||||||||
| Sales M GBP |
Released Forecast Spread | 7 418 7 888 -6,0% | 7 581 | |||||||||||||||||||||||||
| Operating income (EBITDA) M GBP |
Released Forecast Spread | 2 041 2 307 -12% | 2 198 | |||||||||||||||||||||||||
| Operating profit (EBIT) M GBP |
Released Forecast Spread | 1 881 1 835 2,5% | 1 735 | |||||||||||||||||||||||||
| Pre-Tax Profit (EBT) M GBP |
Released Forecast Spread | 1 518 967 57% | 1 154 | |||||||||||||||||||||||||
| Net income M GBP |
Released Forecast Spread | 1 073 534 101% | 519 | |||||||||||||||||||||||||
| EPS GBP |
Released Forecast Spread | 0,21 0,12 73% | 0,11 | |||||||||||||||||||||||||
| Announcement Date | 04/28/2021 | - | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
